Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Yet a run of phase 3 readouts, culminating in a direct comparison against Eli Lillys tirzepatide, has produced a more complicated verdict
The latter may be caused by intestinal disorders, infections, bariatric surgery, or pharmacological interference, including histamine H2 receptor antagonists and metformin
Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
That it is banned might be proof that BPC-157 is some real-deal shit, this guys thinking might go, but USADAs rationale is more about what isnt proven: This substance is not approved for human clinical use by any global regulatory authority and it may lead to negative health effects, says a statement on its website
